31.12.2014 Views

A Case Study - BVMarketData

A Case Study - BVMarketData

A Case Study - BVMarketData

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Business Valuation Update <br />

From the developers of Pratt’s Stats®<br />

Timely news, analysis, and resources for defensible valuations<br />

Vol. 16, No. 12, December 2010<br />

Using the Butler Pinkerton Calculator: A <strong>Case</strong> <strong>Study</strong><br />

By Andrew M. Malec, Ph.D.<br />

In our valuation practice, we often find ourselves<br />

valuing privately held companies where<br />

the investor and the pool of likely buyers for the<br />

investment are not well-diversified. We have<br />

found the Butler Pinkerton Calculator (BPC) to<br />

be a great tool in developing a required rate of<br />

return for such an investor.<br />

The BPC allows the valuation analyst to determine<br />

the required rate of return on equity for a<br />

privately held company by identifying a set of<br />

publicly traded companies that are comparable<br />

to the subject company, and hence, utilize market<br />

information from those guideline companies to<br />

objectively calculate the systematic and unsystematic<br />

risk of those publicly traded stocks.<br />

We have found this information useful in developing<br />

the cost of equity for a privately held<br />

company because the aforementioned calculator<br />

provides market data for the unsystematic<br />

risk premium, as opposed to utilizing a size<br />

premium and subjectively adding a companyspecific<br />

risk premium (CSRP) in a Modified<br />

CAPM, or subjectively applying a CSRP using<br />

a build-up approach. The BPC computes Beta<br />

(systematic risk), as well as Total Beta (systematic<br />

and unsystematic risk) for each of the guideline<br />

companies. Given a size premium, the BPC<br />

can also compute a market derived CSRP for<br />

each of the guideline companies for which an<br />

analyst could consider in determining the CSRP<br />

for the privately held company. Instead of simply<br />

subjectively adding a CSRP, a valuation analyst<br />

can un-lever and re-lever the median CSRP to<br />

estimate the CSRP by using a method such as<br />

the Hamada equation. An analyst might ask the<br />

question, “Can one disaggregate unsystematic<br />

risk between size considerations and other<br />

company-specific events” Even if there is some<br />

overlap, the analyst has to evaluate whether estimating<br />

the CSRP using market data, controlling<br />

for size, is better than a wild guess, as noted in<br />

the following court cases:<br />

Gesoff v. IIC Industries:<br />

This court has also explained that we have been<br />

understandably . . . suspicious of expert valuations<br />

offered at trial that incorporate subjective<br />

measures of company-specific risk premia,<br />

as subjective measures may easily be<br />

employed as a means to smuggle improper<br />

risk assumptions into the discount rate so<br />

as to affect dramatically the expert’s ultimate<br />

opinion on value.<br />

Delaware Open MRI Radiology Associates v.<br />

Howard B. Kessler, et al.:<br />

To judges, the company specific risk<br />

premium often seems like the device experts<br />

employ to bring their final results into line<br />

with their clients’ objectives, when other<br />

valuation inputs fail to do the trick.”<br />

In our practice we use a modified capital asset<br />

pricing model, build-up model, BPC, Duff &<br />

Phelps, LLC Risk Premium Reports, and data from<br />

the Ibbotson SBBI Valuation Yearbooks. Even if a<br />

valuation analyst doesn’t use the BPC in deriving<br />

the cost of equity for a privately held company, an<br />

analyst would find it very helpful to see the marketdetermined,<br />

stand-alone required rates of return for<br />

the publicly traded companies to compare against<br />

the estimated required rate of return on equity for<br />

the subject company. For example, if a valuation<br />

analyst is estimating the required rate of return on<br />

Reprinted with permission from Business Valuation Resources, LLC<br />

BVResources.com


Using the Butler Pinkerton Calculator: A <strong>Case</strong> <strong>Study</strong><br />

Business Valuation Update<br />

Executive Editor:<br />

Jan Davis<br />

Legal Editor:<br />

Sherrye Henry Jr.<br />

CEO, Publisher:<br />

David Foster<br />

Managing Editor:<br />

Janice Prescott<br />

Contributing Editors:<br />

Adam Manson,<br />

Vanessa Pancic, Doug Twitchell<br />

Graphic & Technical Designer: Paul Erdman<br />

Customer Service:<br />

Stephanie Crader<br />

Sales and Site Licenses: Linda Mendenhall<br />

President:<br />

Lucretia Lyons<br />

Editorial Advisory Board<br />

NEIL J. BEATON<br />

CPA/ABV, CFA, ASA<br />

GRANT THORNTON<br />

SEATTLE, WASH.<br />

JOHN A. BOGDANSKI, ESQ.<br />

LEWIS & CLARK<br />

LAW SCHOOL<br />

PORTLAND, ORE.<br />

NANCY J. FANNON<br />

ASA, CPA/ABV, MCBA<br />

FANNON VALUATION GROUP<br />

PORTLAND, ME.<br />

JAY E. FISHMAN<br />

FASA, CBA<br />

FINANCIAL RESEARCH<br />

ASSOCIATES<br />

BALA CYNWYD, PA.<br />

LYNNE Z. GOLD-BIKIN, ESQ.<br />

WOLF, BLOCK, SCHORR<br />

& SOLIS-COHEN<br />

NORRISTOWN, PA.<br />

LANCE S. HALL, ASA<br />

FMV OPINIONS<br />

IRVINE, CALIF.<br />

JAMES R. HITCHNER<br />

CPA/ABV, ASA<br />

THE FINANCIAL<br />

VALUATION GROUP<br />

ATLANTA, GA.<br />

JARED KAPLAN, ESQ.<br />

MCDERMOTT, WILL & EMERY<br />

CHICAGO, ILL.<br />

JAMES S. RIGBY, ASA, CPA/ABV<br />

IN MEMORIAM (1946 – 2009)<br />

GILBERT E. MATTHEWS CFA<br />

SUTTER SECURITIES<br />

INCORPORATED<br />

SAN FRANCISCO, CALIF.<br />

Z. CHRISTOPHER MERCER<br />

ASA, CFA<br />

MERCER CAPITAL<br />

MEMPHIS, TENN.<br />

JOHN W. PORTER<br />

BAKER & BOTTS<br />

HOUSTON, TX.<br />

RONALD L. SEIGNEUR<br />

MBA CPA/ABV CVA<br />

SEIGNEUR GUSTAFSON<br />

LAKEWOOD, COLO.<br />

BRUCE SILVERSTEIN, ESQ.<br />

YOUNG, CONAWAY, STARGATT<br />

& TAYLOR<br />

WILMINGTON, DEL.<br />

JEFFREY S. TARBELL<br />

ASA, CFA<br />

HOULIHAN LOKEY<br />

SAN FRANCISCO, CALIF.<br />

GARY R. TRUGMAN<br />

ASA, CPA/ABV, MCBA, MVS<br />

TRUGMAN VALUATION<br />

ASSOCIATES<br />

PLANTATION, FLA.<br />

KEVIN R. YEANOPLOS<br />

CPA/ABV/CFF, ASA<br />

BRUEGGEMAN & JOHNSON<br />

YEANOPLOS, P.C.<br />

TUCSON, ARIZ.<br />

Business Valuation Update (ISSN 1088-4882) is published monthly by Business<br />

Valuation Resources, LLC, 1000 SW Broadway, Suite 1200, Portland, OR, 97205-<br />

3035. Periodicals Postage Paid at Portland, OR, and at additional mailing offices.<br />

Postmaster: Send address changes to Business Valuation Update, Business<br />

Valuation Resources, LLC, 1000 SW Broadway, Suite 1200, Portland, OR, 97205-3035.<br />

The annual subscription price for the Business Valuation Update is $359. Low<br />

cost site licenses are available for those wishing to distribute the BVU to their colleagues<br />

at the same address. Contact our sales department for details. Please feel<br />

free to contact us via email at customerservice@BVResources.com, via phone at<br />

503-291-7963, via fax at 503-291-7955 or visit our web site at BVResources.com.<br />

Editorial and subscription requests may be made via email, mail, fax or phone.<br />

Please note that by submitting material to BVU, you are granting permission for the<br />

newsletter to republish your material in electronic form.<br />

Although the information in this newsletter has been obtained from sources that<br />

BVR believes to be reliable, we do not guarantee its accuracy, and such information<br />

may be condensed or incomplete. This newsletter is intended for information purposes<br />

only, and it is not intended as financial, investment, legal, or consulting advice.<br />

Copyright 2010, Business Valuation Resources, LLC (BVR). All rights reserved. No<br />

part of this newsletter may be reproduced without express written consent from BVR.<br />

equity for a privately held company for an undiversified<br />

investor at 15% and the BPC is showing<br />

that the total cost of equity is 23% for an undiversified<br />

investor, then the analyst needs to ask if the<br />

investment in the subject company should be less<br />

riskier than that of a publicly traded stock. It may<br />

mean that the analyst is not properly capturing the<br />

required rate of return on equity. We have found<br />

the ability to benchmark the stand-alone, required<br />

rates of return of the publicly traded companies,<br />

and the resulting Total Beta calculation, a valuable<br />

tool in our practice and in supporting our cost of<br />

equity estimates.<br />

For example, we recently valued a company in<br />

the automotive industry where we utilized a buildup<br />

method and a modified capital asset pricing<br />

model to estimate the cost of equity and utilized<br />

the market-derived CSRP from the BPC for our<br />

estimate of the subject company’s CSRP. Since<br />

our CSRP estimate was based on the guideline<br />

companies and objectively determined, as<br />

opposed to subjectively derived, we felt that our<br />

CSRP estimate was reasonable. We also wanted<br />

to ensure that we could address any overlay in<br />

the size premium and the CSRP, so we also utilized<br />

Total Beta to estimate the cost of equity,<br />

calculating similar results. Finally, the median and<br />

average total cost of equity from the guideline<br />

companies was consistent with our required rate<br />

of return estimate, suggesting our cost of equity<br />

estimate was reasonable and provided a “gut<br />

check” on our analysis and a test of reasonableness<br />

to parties involved in the matter.<br />

The BPC does not purport to be the “end all”<br />

in calculating the cost of equity, but presents<br />

another economic model for the analyst to consider<br />

in estimating such cost. In our opinion, the<br />

BPC is a tool that all valuation analysts should<br />

have in their toolbox.<br />

Andrew M. Malec, Ph.D., is managing director of<br />

valuation, litigation advisory & forensic services<br />

at Gordon Advisors PC inTroy, Mich.<br />

Reprinted with permissions from<br />

Business Valuation Resources, LLC<br />

2 Business Valuation Update December 2010

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!